PTC Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results on Thursday, Feb. 19, 2026 [Yahoo! Finance]
PTC Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results on Thursday, Feb. 19, 2026
PTC Therapeutics (NASDAQ:PTCT) had its "hold" rating reaffirmed by analysts at TD Cowen.
PTC Therapeutics (NASDAQ:PTCT) was upgraded by analysts at Barclays PLC from an "equal weight" rating to an "overweight" rating.
PTC Therapeutics Provides Update at J.P. Morgan Annual Healthcare Conference [Yahoo! Finance]